Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 250,000 ATNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 250,000 | n/a |
| Jan 15, 2025 | CorMedix Inc. (CRMD) | Tax Withholding | 6,515 | $72.9K |
| Jan 7, 2025 | CorMedix Inc. (CRMD) | Grant/Award | 62,500 | n/a |
| Jan 18, 2024 | CorMedix Inc. (CRMD) | Grant/Award | 50,000 | n/a |
| Jan 18, 2023 | CorMedix Inc. (CRMD) | Grant/Award | 125,000 | n/a |
| Dec 7, 2021 | CorMedix Inc. (CRMD) | Purchase | 1,000 | $4.5K |
| Dec 7, 2021 | CorMedix Inc. (CRMD) | Purchase | 1,000 | $4.5K |
| Nov 19, 2021 | CorMedix Inc. (CRMD) | Purchase | 1,000 | $5.1K |
| Nov 10, 2021 | CorMedix Inc. (CRMD) | Grant/Award | 125,000 | n/a |
| Jan 14, 2021 | CorMedix Inc. (CRMD) | Grant/Award | 80,000 | n/a |